5-HT reuptake inhibitors in healthy human subjects.
D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use*; D016666:Fluvoxamine; D006801:Humans; D009483:Neuropsychological Tests; D010091:Oximes / Q000009:adverse effects / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use*; D011594:Psychometrics; D012701:Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*
D010091:Oximes; D011437:Propylamines; D012702:Serotonin Antagonists; D005473:Fluoxetine; D012701:Serotonin; D016666:Fluvoxamine